[1]
A. Chakravarthy V, S. Bbv, and P. K. A, “METHOD DEVELOPMENT AND VALIDATION OF ULTRAVIOLET-VISIBLE SPECTROSCOPIC METHOD FOR THE ESTIMATION OF HEPATITIS-C DRUGS - DACLATASVIR AND SOFOSBUVIR IN ACTIVE PHARMACEUTICAL INGREDIENT FORM”, Asian J Pharm Clin Res, vol. 9, no. 9, pp. 61–66, Dec. 2016.